Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
Eli Lilly and Company
I-Mab Biopharma US Limited
Tempus AI
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Hoffmann-La Roche
Elevation Oncology
Intensity Therapeutics, Inc.
Novartis
Pfizer
Massachusetts General Hospital
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Montefiore Medical Center
Ludwig Institute for Cancer Research
Abramson Cancer Center at Penn Medicine
Pfizer
Five Prime Therapeutics, Inc.
Incyte Corporation
Wake Forest University Health Sciences
Institut Bergonié
Merck Sharp & Dohme LLC
King Chulalongkorn Memorial Hospital
Brown University
Ipsen
Icahn School of Medicine at Mount Sinai
Eli Lilly and Company
Stanford University
Amgen
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Novartis
Merrimack Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Curis, Inc.
National Institutes of Health Clinical Center (CC)
Altor BioScience
Verastem, Inc.